Single-blind Control Group Experimental Design
Also known as: single-masked controlled experiment, single-blind controlled trial, SB-CGD, single-blind parallel-group design
A single-blind control group experimental design is a controlled experiment in which participants are kept unaware of whether they are receiving the active treatment or a control condition, while researchers and outcome assessors remain unmasked. The design uses a designated control group as the baseline for comparison, allowing causal inference about the treatment effect while limiting participant-driven response biases such as the placebo effect and demand characteristics.
Key highlights
- Eliminates participant expectation bias, a major threat to internal validity in behavioral and clinical studies.
- The control group provides a contemporaneous baseline, ruling out history and maturation as alternative explanations.
- Simpler to implement than double-blind designs when blinding investigators is impractical or unethical.
- Supports causal inference when combined with randomization, satisfying the gold-standard requirement for many funding bodies and journals.
- Compatible with CONSORT reporting guidelines, facilitating transparent publication and replication.
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
Use this design when you need causal evidence that a treatment causes an outcome, participant expectation effects are plausible (placebo or nocebo effects, demand characteristics), and it is feasible to keep participants unaware of their group. It is appropriate in clinical, behavioral, educational, and social science experiments where a clear control condition can be defined. Do not use it when full double-blinding is achievable and ethically permissible — double-blinding provides stronger protection against bias. Avoid it when randomization is ethically or logistically impossible (consider a quasi-experimental or natural experiment instead), when the intervention itself makes blinding obvious to participants (e.g., surgery vs. no surgery), or when the outcome measure requires blinded assessment by clinicians (choose double-blind instead).
Strengths & limitations
- Eliminates participant expectation bias, a major threat to internal validity in behavioral and clinical studies.
- The control group provides a contemporaneous baseline, ruling out history and maturation as alternative explanations.
- Simpler to implement than double-blind designs when blinding investigators is impractical or unethical.
- Supports causal inference when combined with randomization, satisfying the gold-standard requirement for many funding bodies and journals.
- Compatible with CONSORT reporting guidelines, facilitating transparent publication and replication.
- Investigator knowledge of group assignment can introduce assessment bias, particularly when outcome measurement involves clinical judgment or observer ratings.
- Participant blinding may be compromised if treatment side-effects or characteristics reveal group membership, eroding the masking benefit.
- Requires careful development and validation of a credible control condition (placebo or active comparator); a poorly matched control inflates apparent treatment effects.
- Does not control for investigator expectancy effects, which can influence how the intervention is delivered or how outcomes are recorded.
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
What is the difference between single-blind and double-blind designs?
In a single-blind design only participants are masked to group assignment; investigators and assessors know who received what. In a double-blind design both participants and investigators (and often assessors) are masked. Double-blinding provides stronger protection against bias because it also prevents investigator expectancy from influencing treatment delivery and outcome measurement.
Is randomization required for this design?
Randomization is strongly recommended and is what makes the design a true experiment capable of supporting causal inference. Without randomization — for example when groups are assigned by convenience — the design becomes quasi-experimental and confounding cannot be ruled out as an explanation for observed differences.
How do I verify that blinding actually worked?
After the study, ask participants to guess their group assignment and compare the accuracy of their guesses to chance (50% correct for a two-group study). Reporting blinding integrity is required by CONSORT guidelines. If blinding was substantially compromised, this must be acknowledged as a limitation and considered when interpreting effect sizes.
When is an active comparator better than a placebo as the control condition?
An active comparator (standard care or established treatment) is preferable when withholding treatment would be unethical, when the research question is comparative effectiveness rather than efficacy against no treatment, or when a plausible placebo cannot be constructed. Active comparators also help maintain blinding when a placebo would be obviously inert.
Can I use this design in behavioral or social science research?
Yes. Single-blind controlled designs are used in psychology, education, and social science whenever the experimental treatment can be delivered without participants knowing the active component — for example, a mindfulness training delivered through an app where the control group uses a structurally equivalent app without mindfulness content. The key requirement is a credible control condition that participants cannot easily distinguish from the treatment.
Sources
- 1.Shadish, W. R., Cook, T. D., & Campbell, D. T. (2002). Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Houghton Mifflin.ISBN 978-0395615560
- 2.Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332.
You have read it. What now?
Cite this page
ScholarGate. (2026, June 3). Single-blind control group experimental design. ScholarGate. https://scholargate.app/experimental-design/single-blind-control-group-experimental-design